INCISENT LABS GROUP LLC – Trademark Portfolio
Entity Type: 03
INCISENT LABS GROUP LLC holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 11 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MAX and MAX AD. The owner is based in CHICAGO, IL.
833 WEST JACKSON STREET
SUITE 800
CHICAGO, IL 60607
Showing of trademarks Trademarks
Trademark Classifications
INCISENT LABS GROUP LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does INCISENT LABS GROUP LLC have?
INCISENT LABS GROUP LLC has 14 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 10 cancelled.
What trademark classes does INCISENT LABS GROUP LLC file in?
INCISENT LABS GROUP LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are INCISENT LABS GROUP LLC's most well-known trademarks?
INCISENT LABS GROUP LLC's registered trademark portfolio includes well-known marks such as MAX and MAX AD. These are among 2 currently registered trademarks in the portfolio.
What is INCISENT LABS GROUP LLC's trademark registration success rate?
INCISENT LABS GROUP LLC has a 14% trademark registration rate, with 2 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.